Literature DB >> 4812392

Treatment of psoriasis with azathioprine.

A Du Vivier, D D Munro, J Verbov.   

Abstract

Azathioprine treatment benefited 19 (66%) out of 29 patients suffering from severe psoriasis. Haematological complications were not troublesome and results of biochemical liver function tests remained normal. Minimal cholestasis was seen in two cases and portal fibrosis of a reversible degree in eight. Liver biopsies should be undertaken at regular intervals if azathioprine therapy is continued so that structural liver damage may be detected at an early and reversible stage.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812392      PMCID: PMC1632899          DOI: 10.1136/bmj.1.5897.49

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  METHOTREXATE-INDUCED HEPATIC INJURY IN AN ADULT. A CASE REPORT.

Authors:  R A O'ROURKE; G E ECKERT
Journal:  Arch Intern Med       Date:  1964-02

2.  Treatment of psoriasis with mercaptopurine.

Authors:  R E KRAVETZ; T BALSAM
Journal:  Arch Dermatol       Date:  1961-10

3.  Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

Authors:  J COLSKY; E M GREENSPAN; T N WARREN
Journal:  AMA Arch Pathol       Date:  1955-02

4.  Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

Authors:  R GUBNER; S AUGUST; V GINSBERG
Journal:  Am J Med Sci       Date:  1951-02       Impact factor: 2.378

5.  Azathioprine in psoriasis.

Authors:  M W Greaves; R Dawber
Journal:  Br Med J       Date:  1970-04-25

Review 6.  Azathioprine therapy of "autoimmune" diseases.

Authors:  C C Corley; H E Lessner; W E Larsen
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

7.  The effect of methotrexate, corticosteroids and azathioprine on fingernail growth in psoriasis.

Authors:  R P Dawber
Journal:  Br J Dermatol       Date:  1970-12       Impact factor: 9.302

8.  [Trial therapy of psoriasis with azathioprine].

Authors:  J Hewitt; J P Escande; M Leibowitch; P Franceschini
Journal:  Bull Soc Fr Dermatol Syphiligr       Date:  1970
  8 in total
  16 in total

1.  Severe cholestasis due to azathioprine in Behcet's disease.

Authors:  Kadir Gisi; Murat Ispiroglu; Bulent Kantarceken; Hamide Sayar
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism.

Authors:  Chaker Ben Salem; Lynda Ben Salah; Colandane Belajouza; Kamel Bouraoui
Journal:  Pharm World Sci       Date:  2010-10-23

Review 3.  Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists.

Authors: 
Journal:  BMJ       Date:  1991-10-05

4.  Destructive arthropathy after successful renal transplantation.

Authors:  F Eggelmeijer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

5.  Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.

Authors:  C Nataf; G Feldmann; D Lebrec; C Degott; J M Descamps; B Rueff; J P Benhamou
Journal:  Gut       Date:  1979-06       Impact factor: 23.059

6.  Azathioprine hypersensitivity manifesting as acute focal hepatocellular necrosis.

Authors:  C Cooper; D W Cotton; N Minihane; M I Cawley
Journal:  J R Soc Med       Date:  1986-03       Impact factor: 5.344

7.  Fast atrial fibrillation induced by treatment of psoriasis with azathioprine.

Authors:  H J Dodd; F M Tatnall; I Sarkany
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

8.  Sclerosing hepatitis and azathioprine.

Authors:  J A Barrowman; P K Kutty; M U Ra; S N Huang
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 9.  Psoriasis: current concepts in management.

Authors:  L Hodge; J S Comaish
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

10.  Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy.

Authors:  Ramji Gupta
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.